Mitchell W. Kitayama - 15 Sep 2025 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Role
Director
Signature
/s/ Kathy Diep, as Attorney-in-Fact
Issuer symbol
ASTH
Transactions as of
15 Sep 2025
Net transactions value
-$253,859
Form type
4
Filing time
15 Sep 2025, 16:15:35 UTC
Previous filing
13 Jun 2025
Next filing
12 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kitayama Mitchell W Director C/O ASTRANA HEALTH, INC., 1668 S. GARFIELD AVE, 2ND FLOOR, ALHAMBRA /s/ Kathy Diep, as Attorney-in-Fact 15 Sep 2025 0001333154

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASTH Common Stock Options Exercise $145,600 +8,000 +38% $18.20 29,060 15 Sep 2025 Direct
transaction ASTH Common Stock Disposed to Issuer $241,840 -8,000 -28% $30.23 21,060 15 Sep 2025 Direct F1
transaction ASTH Common Stock Disposed to Issuer $157,619 -5,214 -25% $30.23 15,846 15 Sep 2025 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ASTH Stock Option (right to buy) Options Exercise $0 -8,000 -40% $0.000000 12,000 15 Sep 2025 Common Stock 8,000 $18.20 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were repurchased by the Issuer.
F2 These stock options were fully vested and exercisable.
F3 Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.